Chiesi Global Rare Diseases
ApoPharma is a subsidiary of Apotex Inc., the largest pharmaceutical company in Canada. ApoPharma specializes in the discovery, development and commercialization of innovative medications, primarily for the treatment of rare diseases. ApoPharma’s main focus is in iron metabolism disorders; specifically, the development of drugs for the treatment of iron overload.